SE0202613D0 - Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning - Google Patents

Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning

Info

Publication number
SE0202613D0
SE0202613D0 SE0202613A SE0202613A SE0202613D0 SE 0202613 D0 SE0202613 D0 SE 0202613D0 SE 0202613 A SE0202613 A SE 0202613A SE 0202613 A SE0202613 A SE 0202613A SE 0202613 D0 SE0202613 D0 SE 0202613D0
Authority
SE
Sweden
Prior art keywords
substances
bacteria
virulence
probes
modify
Prior art date
Application number
SE0202613A
Other languages
English (en)
Inventor
Anna Maria Kauppi
Jan Mikael Christian Elofsson
Hans Olof Wolf-Watz
Olov Roland Nordfelth
Markus Kristofer Dahlgren
Original Assignee
Innate Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innate Pharmaceuticals Ab filed Critical Innate Pharmaceuticals Ab
Priority to SE0202613A priority Critical patent/SE0202613D0/sv
Publication of SE0202613D0 publication Critical patent/SE0202613D0/sv
Priority to AU2003256215A priority patent/AU2003256215A1/en
Priority to EP03794402A priority patent/EP1543148A1/en
Priority to PCT/SE2003/001381 priority patent/WO2004022775A1/en
Priority to US10/526,461 priority patent/US7351861B2/en
Priority to EP10161123A priority patent/EP2210597A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/42—Y being a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/88—Nicotinoylhydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0202613A 2002-09-04 2002-09-04 Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning SE0202613D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0202613A SE0202613D0 (sv) 2002-09-04 2002-09-04 Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning
AU2003256215A AU2003256215A1 (en) 2002-09-04 2003-09-04 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
EP03794402A EP1543148A1 (en) 2002-09-04 2003-09-04 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
PCT/SE2003/001381 WO2004022775A1 (en) 2002-09-04 2003-09-04 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
US10/526,461 US7351861B2 (en) 2002-09-04 2003-09-04 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
EP10161123A EP2210597A3 (en) 2002-09-04 2003-09-04 Bacterial virulence modifying agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202613A SE0202613D0 (sv) 2002-09-04 2002-09-04 Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning

Publications (1)

Publication Number Publication Date
SE0202613D0 true SE0202613D0 (sv) 2002-09-04

Family

ID=20288889

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202613A SE0202613D0 (sv) 2002-09-04 2002-09-04 Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning

Country Status (5)

Country Link
US (1) US7351861B2 (sv)
EP (2) EP1543148A1 (sv)
AU (1) AU2003256215A1 (sv)
SE (1) SE0202613D0 (sv)
WO (1) WO2004022775A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202613D0 (sv) * 2002-09-04 2002-09-04 Innate Pharmaceuticals Ab Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning
WO2006083266A1 (en) * 2004-05-07 2006-08-10 Janssen Pharmaceutica, N.V. Inhibitors of bacterial type iii protein secretion systems
US20050282824A1 (en) * 2004-05-07 2005-12-22 Xiaobing Li Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems
JP2008540487A (ja) * 2005-05-11 2008-11-20 ノボ ノルディスク アクティーゼルスカブ 肥満症の治療に有用な新規ハロアルキルスルホン置換化合物
WO2006132583A1 (en) * 2005-06-07 2006-12-14 Innate Pharmaceuticals Ab Method and means for preventing and inhibiting respiratory disease, atherosclerosis and osteoporosis caused by chlamydia pneumoniae infection
GB2429283B8 (en) * 2006-08-01 2013-04-10 Univ Hertfordshire Higher Education Corp Preservative efficacy testing
ATE486283T1 (de) * 2006-08-14 2010-11-15 Biocontrol Systems Inc Verfahren zur erkennung von listerien
WO2009145829A1 (en) 2008-04-01 2009-12-03 University Of Massachusetts Type iii secretion inhibitors, analogs and uses thereof
CN105566147B (zh) 2015-12-07 2018-03-09 北京信德润兴科技有限公司 一种化合物及其制备方法和用途及相应的靶向给药系统和化疗药物
WO2018232298A1 (en) * 2017-06-16 2018-12-20 The Research Foundation For The State University Of New York Anti-fungals compounds targeting the synthesis of fungal sphingolipids

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU173047B (hu) * 1975-03-20 1979-02-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh salicilanilidov
FR2336931A1 (fr) * 1975-12-30 1977-07-29 Dick Pierre Compositions anthelminthiques a base de benzimidazoles
SU1226807A1 (ru) 1984-10-10 1992-05-07 Ивановский сельскохозяйственный институт Способ получени 2-ацетокси-4 @ -хлор-3,5-дийодбензанилида
SU1685935A1 (ru) 1989-12-21 1991-10-23 Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского 2-[(Бензо-2,1,3-тиадиазол-4-сульфонил)амино] бензойные кислоты в качестве промежуточных продуктов в синтезе N-(4-хлорфенил)- или N-(3,4-дихлорфенил)-2-[(бензо-2,1,3-тиадиазол-4-сульфонил)амино]-5-хлорбензамида, обладающих антигельминтной активностью
SU1715357A1 (ru) * 1990-04-09 1992-02-28 Ивановский сельскохозяйственный институт Способ лечени фасциолеза и мониезиоза овец
US6180604B1 (en) 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
WO1999011262A1 (en) * 1997-09-02 1999-03-11 Roche Diagnostics Gmbh Mpl-receptor ligands, process for their preparation, medicaments containing them and their use for the treatment and prevention of thrombocytopaenia and anaemia
US6136542A (en) * 1998-05-13 2000-10-24 Institut Pasteur Method for screening for inhibitors and activators of type III secretion machinery in gram-negative bacteria
US6136541A (en) * 1999-02-22 2000-10-24 Vialogy Corporation Method and apparatus for analyzing hybridized biochip patterns using resonance interactions employing quantum expressor functions
GB2365426A (en) * 2000-08-01 2002-02-20 Pantherix Ltd Bactericidal benzamide derivatives
US6846933B1 (en) * 2000-10-30 2005-01-25 The Board Of Trustees Of Wellesley College Antimycobacterial compounds and method for making the same
US20040110963A1 (en) 2001-01-22 2004-06-10 Kaspar Burri Novel hydrazones
SE0202613D0 (sv) * 2002-09-04 2002-09-04 Innate Pharmaceuticals Ab Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning

Also Published As

Publication number Publication date
US7351861B2 (en) 2008-04-01
WO2004022775A8 (en) 2005-05-12
EP1543148A1 (en) 2005-06-22
EP2210597A2 (en) 2010-07-28
EP2210597A3 (en) 2011-01-12
US20060134724A1 (en) 2006-06-22
AU2003256215A1 (en) 2004-03-29
WO2004022775A1 (en) 2004-03-18
AU2003256215A8 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
DK1558579T3 (da) N-alkyl-4-methylenamino-3-hydroxy-2-pyridoner som antimikrobialer
ATE362360T1 (de) Hemmer des phosphattransports
BR0014470A (pt) Inibidores de fab i
SE0202613D0 (sv) Förfarande och prob för identifiering av ämnen som modifierar bakteriers virulens, som sådana identifierade ämnen samt deras användning
NO20054523L (no) Hydroksymetyl-substituerte dihydroisoksazolderivater som er nyttige som antibiotika
DK0931788T3 (da) Metalloproteasehæmmere
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
ATE514686T1 (de) Neue oxazolidinonderivate
ATE30237T1 (de) Epi-derivat von azahomoerythromycin a und zwischenprodukte.
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
NO20062629L (no) Oksazolderivater av tetrackliner
EA200200699A1 (ru) Оксазолидиноны, обладающие сульфоксиминовой функциональностью
EA202192669A1 (ru) Твердые формы ингибитора бета-лактамазы для пероральной доставки и их применения
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
WO2022106469A3 (en) N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections
EA200200673A1 (ru) Оксазолидиноновые эфиры бензойной кислоты, содержащие гидроксиацетилпиперазиновый заместитель
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
ATE288199T1 (de) Hydroxystilbenverbindungen als mikrobizide wirksubstanzen
NO20053741L (no) Nye 1-acetoksy-3-(substituert fenyl) propen-forbindelser
ATE449775T1 (de) Carbacephem beta-lactam-antibiotika
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
DE69634494D1 (de) Verwendung von Vitamin D Derivaten zur Herstellung eines Medikaments zur Behandlung von BÖSARTIGEN TUMORMETASTASE
ES505430A0 (es) Procedimiento para la preparacion de 3-0-desmenlistamicina b.
TW335392B (en) Process for preparing optically active amines
DE60326710D1 (de) Trizyklische antibakterielle makrolidderivate